A study to assess the effect of CC-95251 alone and in combination with anti-cancer drugs in subjects with Acute Myeloid Leukemia and Myelodysplastic Syndromes

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506117-22-00

Acronym

CA059-001

Enrollment

153

Registered

2024-02-01

Start date

2022-01-05

Completion date

2024-05-28

Last updated

2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia and Myelodysplastic Syndromes

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Norway, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026